S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
66,000% upside on tiny biotech? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
66,000% upside on tiny biotech? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
66,000% upside on tiny biotech? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
66,000% upside on tiny biotech? (Ad)
Stock market today: Asian world shares mostly lower after Wall St has its worst week in 6 months
Oil prices have risen. That's making gas more expensive for US drivers and helping Russia's war
66,000% upside on tiny biotech? (Ad)
Writers Guild and Hollywood studios reach tentative agreement to end strike. No deal yet for actors
AI is on the world's mind. Is the UN the place to figure out what to do about it?
ATTENTION: Digital Dollar Could Send this $0.25 Play Skyrocketing (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Facial recognition technology jailed a man for days. His lawsuit joins others from Black plaintiffs
NASDAQ:LIFW

MSP Recovery (LIFW) Competitors

$0.24
0.00 (-0.29%)
(As of 09/22/2023 08:52 PM ET)
Compare
Today's Range
$0.17
▼
$0.28
50-Day Range
$0.06
▼
$0.24
52-Week Range
$0.04
▼
$1.74
Volume
155.97 million shs
Average Volume
10.93 million shs
Market Capitalization
$815.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

LIFW vs. DCGO, CLOV, EOLS, RNA, WVE, MODV, RPTX, EXAI, THRN, and SVRA

Should you be buying MSP Recovery stock or one of its competitors? The main competitors of MSP Recovery include DocGo (DCGO), Clover Health Investments (CLOV), Evolus (EOLS), Avidity Biosciences (RNA), Wave Life Sciences (WVE), ModivCare (MODV), Repare Therapeutics (RPTX), Exscientia (EXAI), Thorne HealthTech (THRN), and Savara (SVRA). These companies are all part of the "medical" sector.

MSP Recovery vs.

MSP Recovery (NASDAQ:LIFW) and DocGo (NASDAQ:DCGO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation, earnings and community ranking.

DocGo has a consensus price target of $13.60, suggesting a potential upside of 166.67%. Given DocGo's higher possible upside, analysts clearly believe DocGo is more favorable than MSP Recovery.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MSP Recovery
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
DocGo
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

MSP Recovery has a beta of -1.23, meaning that its stock price is 223% less volatile than the S&P 500. Comparatively, DocGo has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500.

6.2% of MSP Recovery shares are held by institutional investors. Comparatively, 52.1% of DocGo shares are held by institutional investors. 19.4% of MSP Recovery shares are held by insiders. Comparatively, 13.8% of DocGo shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

DocGo has higher revenue and earnings than MSP Recovery.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MSP Recovery$23.42M34.83-$7.42MN/AN/A
DocGo$440.52M1.20$34.58M$0.0772.86

DocGo received 27 more outperform votes than MSP Recovery when rated by MarketBeat users.

CompanyUnderperformOutperform
MSP RecoveryN/AN/A
DocGoOutperform Votes
27
65.85%
Underperform Votes
14
34.15%

DocGo has a net margin of 1.27% compared to MSP Recovery's net margin of -29.08%. DocGo's return on equity of 3.20% beat MSP Recovery's return on equity.

Company Net Margins Return on Equity Return on Assets
MSP Recovery-29.08% -15.83% -10.64%
DocGo 1.27%3.20%2.31%

In the previous week, DocGo had 13 more articles in the media than MSP Recovery. MarketBeat recorded 17 mentions for DocGo and 4 mentions for MSP Recovery. MSP Recovery's average media sentiment score of 0.28 beat DocGo's score of 0.04 indicating that MSP Recovery is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
MSP Recovery
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
DocGo
2 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

DocGo beats MSP Recovery on 11 of the 14 factors compared between the two stocks.


Get MSP Recovery News Delivered to You Automatically

Sign up to receive the latest news and ratings for LIFW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIFW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIFW vs. The Competition

Export to Excel
MetricMSP RecoveryData processing & preparation IndustryMedical SectorNASDAQ Exchange
Market Cap$815.75M$3.12B$4.29B$6.25B
Dividend YieldN/A1.80%5.83%9.75%
P/E RatioN/A28.98102.9711.17
Price / Sales34.835.072,890.4356.12
Price / CashN/A25.4928.2625.76
Price / Book0.355.813.844.79
Net Income-$7.42M-$56.87M$119.85M$185.19M
7 Day Performance94.11%1.39%110.53%3.51%
1 Month PerformanceN/A2.51%113.74%8.58%
1 Year PerformanceN/A-8.85%129.84%4.85%

MSP Recovery Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DCGO
DocGo
2.3265 of 5 stars		$5.12
-3.0%		$13.60
+165.6%		-45.8%$531.41M$440.52M73.143,252
CLOV
Clover Health Investments
2.0863 of 5 stars		$1.08
+0.9%		$1.80
+66.7%		-45.5%$523.65M$3.48B-1.96656
EOLS
Evolus
2.1891 of 5 stars		$9.19
+1.0%		$21.40
+132.9%		+10.5%$523.55M$148.62M-7.85215
RNA
Avidity Biosciences
1.7455 of 5 stars		$7.06
-3.3%		$38.17
+440.6%		-65.2%$523.15M$9.22M-2.28186News Coverage
WVE
Wave Life Sciences
2.5 of 5 stars		$5.26
-1.3%		$7.00
+33.1%		+39.1%$520.64M$3.65M-3.87250News Coverage
MODV
ModivCare
2.8581 of 5 stars		$36.48
+4.1%		$67.67
+85.5%		-64.1%$517.32M$2.66B-2.2420,000Positive News
Gap Up
RPTX
Repare Therapeutics
1.8868 of 5 stars		$13.01
+3.5%		$20.75
+59.5%		+1.6%$547.59M$131.83M-86.73180Negative News
High Trading Volume
EXAI
Exscientia
1.6998 of 5 stars		$4.53
-10.5%		$13.00
+187.0%		-29.8%$547.63M$32.90M-3.12481Positive News
High Trading Volume
THRN
Thorne HealthTech
2.0832 of 5 stars		$10.16
flat		$7.80
-23.2%		+105.5%$547.83M$228.73M26.74544Positive News
SVRA
Savara
1.9321 of 5 stars		$3.77
-1.8%		$5.00
+32.6%		+166.2%$509.59M$260,000.00-13.46N/A

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NASDAQ:LIFW) was last updated on 9/25/2023 by MarketBeat.com Staff

My Account -